Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Content provided by Audioboom. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
S3 Ep29: A Simple Blood Test To Detect Lung Cancer w/ Allan Syms Chairman Cizzle Biotech
MP3•Episode home
Manage episode 347649284 series 2721332
Content provided by Audioboom. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this podcast Mark Fairbairn & Kenny Russell talk to Allan Syms the Exceutive Chairman of Cizzle Biotech. The compnay are working on developing a blood test to detect early stage lung cancer. With 13 years of research already behind them, their IPO June 2021 opened the way to develop the science into a marketable product.
00:00 - Introduction to Allan
09:40 - Allan's Interest in Science
5:14 - The Jump into Industry
22:56 - Working for Big Pharma
25:35 - Scientist or Business Man?
29:16 - Failures Along the Way
32:07 - Allan's Joins Cizzle
35:58 - The Cizzle Investment Case
00:00 - Introduction to Allan
09:40 - Allan's Interest in Science
5:14 - The Jump into Industry
22:56 - Working for Big Pharma
25:35 - Scientist or Business Man?
29:16 - Failures Along the Way
32:07 - Allan's Joins Cizzle
35:58 - The Cizzle Investment Case
223 episodes
MP3•Episode home
Manage episode 347649284 series 2721332
Content provided by Audioboom. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this podcast Mark Fairbairn & Kenny Russell talk to Allan Syms the Exceutive Chairman of Cizzle Biotech. The compnay are working on developing a blood test to detect early stage lung cancer. With 13 years of research already behind them, their IPO June 2021 opened the way to develop the science into a marketable product.
00:00 - Introduction to Allan
09:40 - Allan's Interest in Science
5:14 - The Jump into Industry
22:56 - Working for Big Pharma
25:35 - Scientist or Business Man?
29:16 - Failures Along the Way
32:07 - Allan's Joins Cizzle
35:58 - The Cizzle Investment Case
00:00 - Introduction to Allan
09:40 - Allan's Interest in Science
5:14 - The Jump into Industry
22:56 - Working for Big Pharma
25:35 - Scientist or Business Man?
29:16 - Failures Along the Way
32:07 - Allan's Joins Cizzle
35:58 - The Cizzle Investment Case
223 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.